European Pharmacopoeia Ph Eur Monograph Tablets 0478 Better Jun 2026

This test measures the rate at which the active substance is released into a liquid medium. It serves as a proxy for how the drug might behave in the digestive tract. Disintegration:

: Requires rigorous physical and analytical verification before batch clearance. This involves checking mass uniformity and disintegration behavior. 🔬 Critical Quality Control Testing Procedures

The 0478 monograph mandates that tablets must pass specific disintegration tests (2.9.1) to ensure they break down properly in the gastrointestinal tract.

A material is considered of pharmacopoeial quality only if it complies with the requirements stated in the monograph and any other applicable texts.

This detailed classification helps manufacturers precisely define their product, and regulators to evaluate it against the appropriate performance criteria. european pharmacopoeia ph eur monograph tablets 0478 better

To satisfy the legally binding rules of the EDQM, finished batches must successfully pass a comprehensive array of physical and analytical validations. Specific monographs: Finished products - EDQM

The (e.g., highly soluble, poorly soluble, low-dose, moisture-sensitive)

Monograph 0478 outlines the general characteristics, production standards, and mandatory tests for compressed oral solid dosage forms. The core compliance checklist includes:

For pharmaceutical manufacturers, adopting the current, updated 0478 monograph is not just a regulatory requirement—it is a commitment to producing high-quality, reliable, and safe medicinal products. This test measures the rate at which the

Monograph number is officially titled "Tablets." It is a general monograph, meaning it applies not to a specific drug (like paracetamol) but to the dosage form itself. It dictates the mandatory tests, procedures, and acceptance criteria that any tablet—whether immediate-release, effervescent, or orodispersible—must meet to be considered compliant within the EU.

By designing testing protocols that meet the stringent demands of Ph. Eur. Monograph 0478, manufacturers often inherently satisfy global regulatory expectations, facilitating smoother multi-market registrations and broader market access.

: Mandates strict physical parameters during large-scale compression. This includes maintaining the uniform flow of granules and handling microbiological purity under General Chapter 5.1.

Common mistake: Using USP parameters for a Ph. Eur. submission. simulated gastric fluid).

Implementing QbD principles means defining a Critical Quality Attribute (CQA)—such as a 15-minute disintegration target under Monograph 0478—and designing the formulation and process parameters to guarantee that outcome. By understanding the design space, manufacturers reduce batch failures and optimize production efficiency. Process Analytical Technology (PAT)

Monograph 0478 is better because it is preventative (forcing tight manufacturing controls) rather than detective (finding problems after they happen). It demands a higher process capability index (Cpk) from your tablet press.

This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.

This test measures the time required for a tablet to break up into a soft mass in a liquid medium.

Often caused by trapped air or excessive compression speed. Can be resolved by adjusting pre-compression force and optimizing binder ratios.